DOAC for AF — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Apixaban 5 mg BD
CHA₂DS₂-VASc ≥2 in males (≥3 in females) warrants oral anticoagulation. DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) are preferred over warfarin (superior safety profile, no monitoring). Apixaban has the best safety data in elderly patients (ARISTOTLE trial: lower major bleeding than warfarin). Aspirin alone is NOT recommended for stroke prevention in AF (inferior to anticoagulation with similar bleeding risk — AVERROES trial).
Reference: CSANZ – 2024 – AF; ESC 2024 AF Guidelines